ANZTCT practice statement: sinusoidal obstruction syndrome/veno-occlusive disease diagnosis and management
- Author(s)
- Fleming, S; Scott, AP; Coutsouvelis, J; Fraser, C; Bajel, A; Nelson, A; Conyers, R; McEwan, A; Yeung, D; Campion, V; Teague, L; McGuire, M; Morris, E; Gabriel, M; Wayte, R; Douglas, G; Chien, N; Hamad, N;
- Details
- Publication Year 2024-09,Volume 54,Issue #9,Page 1548-1556
- Journal Title
- Internal Medicine Journal
- Publication Type
- Review
- Abstract
- Sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) is a life-threatening complication which can develop after haemopoietic stem cell transplantation (HSCT) and some antibody-drug conjugates. Several SOS/VOD diagnostic and management guidelines exist, with the most recent and refined being the European Society for Blood and Marrow Transplantation adult and paediatric guidelines. Timely diagnosis and effective management (including the availability of therapeutic options) significantly contribute to improved patient outcomes. In Australia and New Zealand, there is variability in clinical practice and access to SOS/VOD therapies. This review aims to summarise the current evidence for SOS/VOD diagnosis, prevention and treatment and to provide recommendations for SOS/VOD in the context of contemporary Australasian HSCT clinical practice.
- Publisher
- Wiley
- Keywords
- Humans; *Hepatic Veno-Occlusive Disease/diagnosis/therapy; *Hematopoietic Stem Cell Transplantation/adverse effects; Australia; New Zealand; Disease Management; Practice Guidelines as Topic; Sos/vod; haemopoietic stem cell transplantation; sinusoidal obstruction syndrome; sinusoidal obstruction syndrome/veno‐occlusive disease
- Department(s)
- Clinical Haematology
- Publisher's Version
- https://doi.org/10.1111/imj.16453
- Open Access at Publisher's Site
https://doi.org/10.1111/imj.16453- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-10-01 05:05:36
Last Modified: 2024-10-01 05:05:56